J&J to begin trial of experimental HIV vaccine later in 2019
About 3,800 men who have sex with men will receive a regimen of injections, director of the US National Institute of Allergy and Infectious Diseases Anthony Fauci says
14 July 2019 - 08:00
London — Johnson & Johnson (J&J) is preparing to test an experimental HIV vaccine in the US and Europe in a move toward developing the first immunisation against the deadly disease after decades of frustration.
About 3,800 men who have sex with men will receive a regimen of shots in a study that’s planned to be launched later in 2019, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said in an interview. The agency and the HIV Vaccine Trials Network of testing sites will collaborate with J&J’s Janssen unit on the effort...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.